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Primary laryngeal aspergillosis is extremely rare, especially in an immunocompetent host.
It is commonly found as a part of systemic infection in immunocompromised patients. A
case of vocal cord aspergillosis with no systemic extension in an immunocompetent pa-
tient on long-term steroid metered dose inhaler (MDI) is presented here, because of its
rarity. The present case is a 28-year-old asthmatic female who was on inhalational steroid
for 8 years, presented with sudden onset of severe dysphonia for 5 days. Fiberoptic
laryngoscopy demonstrated whitish plaque involving right vocal cord, clinically suggestive
of fungal laryngitis. Microlaryngeal laser surgery was performed with stripping of the
plaque. Histopathology demonstrated ulcerated hyperplastic squamous epithelium with
masses of fungal hyphae, which was confirmed to be Aspergillus species on fungal culture.
This rare but serious adverse effect of long-term steroid MDI use must be kept in mind
while treating an asthmatic patient. We also present a brief review of literature of laryngeal
aspergillosis.Aspergillus, an inherently nonpathogenic or weakly patho-
genic fungus, produces a range of opportunistic infections.
The term aspergillosis is used to describe all disease entities
caused by any one of the ~35 pathogenic and allergenic
species of Aspergillus. Only those species that grow at 37 C
can cause invasive aspergillosis. Aspergillus fumigatus is
responsible for the most of the cases of invasive infections,
almost all cases of chronic aspergillosis, and most allergic
syndromes [1]. In the field of otorhinolaryngology, aspergil-
losis most commonly occurs in the external auditory canal
or in the nasal sinuses, but its localization to the larynx ishology and Laboratory M
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mons.org/licenses/by-ncrare, especially in nonimmunocompromised hosts [2].
Laryngeal aspergillosis is most often found in the immu-
nocompromised people such as patients with advanced age,
diabetes, long-term steroid use, COPD, low CD4 counts,
leukemia, AIDS, or severe aplastic anemia [2,3]. To the best
of author knowledge, only 22 cases of primary laryngeal
aspergillosis in nonimmunocompromised patients have
been reported so far. We report a rare case of primary vocal
cord aspergillosis in an asthmatic patient on corticosteroid
inhaler use and briefly review the etiological factors of
laryngeal aspergillosis.edicine, All India Institute of Medical Sciences, Bhubaneswar,
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A 28-year-old female presented with a sudden onset of severe
dysphonia for 5 days. She was an asthmatic and was on
inhalational steroid (fluticasone 500mcg bd) since 8 years. She
also had a history of vocal abuse. She was treated with broad-
spectrum antibiotics, repeatedly during the last 3 months due
to recurrent episodes of lower respiratory tract infection. On
presentation, fiberoptic laryngoscopy showed whitish plaque
involving right vocal cord [Fig. 1A]. Fungal laryngitis was
suspected though keratosis of the vocal cord was a differen-
tial. Videostroboscopy was done to document the mucosal
wave formation. To establish the final diagnosis and to insti-
tute an appropriate treatment, histopathological confirmation
was required. Micro-laryngeal laser surgery was performed,
stripping of the slough under direct vision was done, and bi-
opsy samples and fungal culture were taken. Microscopic
examination showed [Fig. 1B and C] inflamed, ulcerated, hy-
perplastic squamous epithelium, abundant fibrinopurulent
debris, granulation tissue, and colonies of fungal hyphae.
Grocott Methenamine silver stain [Fig. 1D] revealed septate
fungal hyphae in the white plaque, branching at acute angles,
and morphologically resembling Aspergillus sp. A. fumigatus
was isolated on fungal culture. The remainder of the head and
neck examination was unremarkable. Her chest X-ray and
computed tomography/paranasal sinuses showed no abnor-
mality. She was seronegative for HIV, HBV and HBV. The pa-
tient had no history of immune deficiency, leukemia,Fig. 1 e (A) Laryngoscopy showing thick white plaque involving a
showing ulcerated squamous epithelium along with acute inflamm
High power view of the above showing acute branching septate f
stain, respectively (H and E and GMS, 400).malignant diseases, and diabetes mellitus. Inhaled cortico-
steroid was discontinued and the patient was treated with
voriconazole 200mg bd for 8 days and instructionwas given to
maintain vocal hygiene. After 12 days of voice rest, her voice
showed a significant improvement. A repeat video-
stroboscopic examination after 2 weeks showed apparently
normal vocal cords. Since symptom of asthma persisted,
inhalational fluticasone had to be started at a dose of 125 mcg
bd with metered dose inhaler (MDI) using a spacer. Speech
therapy was given for 2 months and her voice regained
normalcy. She has been followed up for 3 years since the onset
of vocal cord aspergillosis. Her voice was absolutely normal.
Videostroboscopy was repeated at 6-month intervals, which
showed normal mucosal wave formation in the vocal cords.
There was no evidence of recurrence.Discussion
Laryngeal aspergillosis is most commonly seen as part of a
broader spectrum of infection, involving the respiratory tract
in immunocompromised people, but Aspergillus infection of
the larynx of immunocompetent individuals have also been
reported [4,5]. After extensive literature search, fewer than 50
cases of primary laryngeal aspergillosis have been reported; of
these, 22 cases involving immunocompetent patients are
summarized in Table 1 [6,7].
Aspergillus sp. is generally a nonpathogenic or weakly
pathogenic fungus causing opportunistic infections.part of the right vocal cord. (B) Low power view of the plaque
atory exudate and fungal hyphae (H and E, 100). (C and D)
ungal hyphae in H and E and Grocott Methenamine silver
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b i om e d i c a l j o u r n a l 3 8 ( 2 0 1 5 ) 5 5 0e5 5 3552Aspergillosis is thought to be caused due to host immunode-
ficiency rather than pathogenicity of the fungus itself [8]. Then
how does healthy people become infected by Aspergillus? At
present, the question still remains unanswered because there
are only few case reports. There are a number of potential
predisposing factors that may be associated with the devel-
opment of primary laryngeal aspergillosis in the immuno-
competent patients. The etiological factors include iatrogenic
factors (including the long-term use of steroid MDI in high-
dose), vocal abuse, vocal-fold cysts, fellatio and occupational
factors [3,8e11].
Among iatrogenic factors, radiotherapy, steroid inhaler
use, and laser treatment are important local factors that may
predispose to the localized forms of aspergillosis [8,9].
Hoarseness of voice is a recognized complication of inhaled
steroid therapy. Overall, it has been reported in 2% of patients
receiving fluticasone and in 1% of patients on beclomethasone
[9]. A significant proportion of inhaled corticosteroid is
deposited in the larynx, especially on superior surface of the
vocal cord, facilitating fungal colonization of the epithelial
surfaces [11].
Systemic factor such as prolonged antibiotic therapy al-
ters the local bacterial flora and disturbs the ecological bal-
ance between bacteria and fungi, thus allowing the
overgrowth of Aspergillus. Several cases of invasive aspergil-
losis have been reported in patients receiving multiple anti-
biotics [10].
As a part of innate immunity, the intact epithelia of the
respiratory tracts provide mechanical barrier to the entry of
microbes from the external environment. Although vocal
abuse may not be the direct cause, but by causing repeated
frictions, it may cause local mucosal membrane barrier injury
and edema, which may facilitate adhesion of the air sus-
pended Aspergillus spores, followed by colonization, hyphae
development, and invasion [10].
Laryngeal aspergillosis can complicate vocal fold cyst
[6,11]. Wittkopf et al. reported a case of submucosal aspergil-
loma of the vocal cord developing in a preexisting vocal cord
cyst [11]. The exact relationship between the cyst and laryn-
geal aspergillosis, however, is not clear.
Aspergillus is a saprophyte, inhabiting the soil. Thus, in
certain otherwise healthy individuals engaged in farming and
carpentry, occupation may be an etiological factor for the
development of primary aspergillosis of larynx [10].
Though the history of oral sex was not present in our case,
fellatio may be a highly suspected predisposing factor. By
repeated friction, fellatio may cause local mucosal membrane
barrier injury and may contribute to the causation of primary
laryngeal aspergillosis in the immunocompetent individuals
[3].
It is often seen that the diagnosis of fungal laryngitis is
overlooked in the immunocompetent patients because it is
generally considered as a disease of the immunocompro-
mised patients, and because it often clinically mimics, more
common and more serious conditions, for example, leuko-
plakia [5]. The laryngoscopic appearance of the vocal cord
aspergillosis varies as with its histopathological appearance.
Ulceration with or without hemorrhage, mass lesion with or
without ulceration, white plaques on the vocal cords, and
surrounding laryngeal structures are commonly described
b i om e d i c a l j o u r n a l 3 8 ( 2 0 1 5 ) 5 5 0e5 5 3 553laryngoscopic findings. Histologically, hyperkeratosis, edema,
and erythema of the surface epithelium have been described
as associated, nonspecific findings. Diffuse necrosis induced
sloughing of epithelium has been reported in a small series by
Ogawa et al. [8,11].
With the usual indolent clinical presentation and lar-
yngoscopic appearances of laryngeal aspergillosis, the
neoplastic lesion is often considered as a primary differential
diagnosis. Equivocal clinical history and histopathological
evidence of acanthosis and pseudoepitheliomatous hyper-
plasia often lead to a mistaken diagnosis of malignancy or
premalignant condition. On the other hand, the presence of
fungal hyphae and vascular emboli, with superimposed ne-
crosis, maymask the underlyingmalignancy, especially in the
setting of recurrent laryngeal cancer [8].
A high index of suspicion is required to reach the diagnosis
and should be considered in any immunocompetent patient
with persistent or refractory laryngitis when the above-
mentioned predisposing factors are present. In these cases,
demonstration of hyperkeratosis, particularly if associated
with intraepithelial polymorphs, on histopathology, should
trigger a search for fungal elements using specialized stains.
Treatment by antifungal is required. The treatment should
also be targeted toward the elimination of any predisposing
factors, as failure to do so, may result in the persistence or
recurrence of the condition.
Conclusion
The occurrence of primary laryngeal aspergillosis in the
immunocompetent patients and in patients with localized
immunosuppression is an emerging trend. We suggest that
asthmatic patients, while taking inhalational steroids if
develop hoarseness of voice should be fully investigated by
laryngoscopy and if required is to be followed by biopsy and
fungal cultures. This case highlights a rare though possible
serious adverse effect, which may result from the use of very
high doses of inhaled corticosteroid therapy. Inhalational
corticosteroids are available as over-the-counter drugs and
people use it often without proper monitoring by pulmonol-
ogists. Hence, this rare but serious complication of the use of
inhalational steroid must be kept in mind during the rampant
use of the same.Source of support
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